Vaxcyte, Inc. (PCVX) Ownership

$85.99

south_east
-$0 (0%)
Day's range
$84.23
Day's range
$85.99

Vaxcyte, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FMR LLC 02/13/2025 13.09 M $1.07 B   -17.15% 10.58%
VANGUARD GROUP INC 02/11/2025 11.96 M $979.18 M   4.56% 9.67%
BLACKROCK FUNDING, INC. /DE 02/07/2025 11.11 M $909.14 M   4.12% 8.98%
JANUS HENDERSON GROUP PLC 02/14/2025 10.58 M $865.61 M   -3.17% 8.55%
RA CAPITAL MANAGEMENT, L.P. 02/14/2025 8.69 M $711.30 M   0.00% 7.02%
CAPITAL RESEARCH GLOBAL INVESTORS 02/13/2025 6.21 M $508.39 M   26.79% 5.02%
WELLINGTON MANAGEMENT GROUP LLP 02/12/2025 4.44 M $363.79 M   -1.55% 3.59%
PRICE T ROWE ASSOCIATES INC /MD/ 02/14/2025 3.97 M $324.74 M   -11.18% 3.21%
GOLDMAN SACHS GROUP INC 02/11/2025 3.13 M $256.19 M   229.69% 2.53%
FRANKLIN RESOURCES INC 02/12/2025 2.87 M $234.88 M   2.98% 2.32%
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. 02/14/2025 2.86 M $234.18 M   -29.43% 2.31%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 2.80 M $229.49 M   3.78% 2.27%
WESTFIELD CAPITAL MANAGEMENT CO LP 02/11/2025 2.57 M $210.11 M   47.53% 2.08%
KYNAM CAPITAL MANAGEMENT, LP 02/14/2025 2.34 M $191.29 M   124.85% 1.89%
ALLIANCEBERNSTEIN L.P. 02/12/2025 1.78 M $145.66 M   8.11% 1.44%
JPMORGAN CHASE & CO 02/12/2025 1.74 M $142.08 M   21.57% 1.40%
PERCEPTIVE ADVISORS LLC 02/14/2025 1.72 M $140.67 M   -15.25% 1.39%
COMMODORE CAPITAL LP 02/14/2025 1.63 M $133.02 M   76.63% 1.31%
PARADIGM BIOCAPITAL ADVISORS LP 02/14/2025 1.42 M $116.47 M   126.66% 1.15%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/06/2025 1.34 M $109.84 M   3.54% 1.08%
JENNISON ASSOCIATES LLC 01/24/2025 1.25 M $102.04 M   0.74% 1.01%
DEUTSCHE BANK AG\ 02/14/2025 1.21 M $99.27 M   5.62% 0.98%
MAVERICK CAPITAL LTD 02/14/2025 1.20 M $98.39 M   23.11% 0.97%
AVORO CAPITAL ADVISORS LLC 02/14/2025 1.18 M $96.19 M   0.00% 0.95%
DRIEHAUS CAPITAL MANAGEMENT LLC 02/14/2025 1.17 M $95.52 M   -32.21% 0.94%
INVESCO LTD. 02/13/2025 1.17 M $95.45 M   -11.13% 0.94%
WOODLINE PARTNERS LP 02/14/2025 1.12 M $91.76 M   1.54% 0.91%
CLEARBRIDGE INVESTMENTS, LLC 02/12/2025 1.10 M $90.25 M   -4.90% 0.89%
NORGES BANK 02/12/2025 1.10 M $90.07 M   100.00% 0.89%
PICTET ASSET MANAGEMENT HOLDING SA 02/12/2025 1.02 M $83.32 M   30.34% 0.82%
POLAR CAPITAL HOLDINGS PLC 02/14/2025 973,645 $79.70 M   -2.22% 0.79%
D. E. SHAW & CO., INC. 02/14/2025 775,653 $63.49 M   83.15% 0.63%
NOVO HOLDINGS A/S 02/14/2025 750,000 $61.40 M   0.00% 0.61%
UBS GROUP AG 02/14/2025 736,561 $60.29 M   560.16% 0.60%
AMERIPRISE FINANCIAL INC 02/14/2025 716,773 $58.68 M   104.70% 0.58%
PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC 02/13/2025 703,834 $57.62 M   10.05% 0.57%
AMERICAN CENTURY COMPANIES INC 02/11/2025 605,267 $49.55 M   14.42% 0.49%
ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC 01/29/2025 593,523 $49.42 M   70.81% 0.48%
ENSIGN PEAK ADVISORS, INC 02/14/2025 586,128 $47.98 M   7.19% 0.47%
BROWN ADVISORY INC 02/14/2025 556,209 $45.53 M   25.26% 0.45%
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. 02/18/2025 539,405 $44.16 M   -38.66% 0.44%
NUVEEN ASSET MANAGEMENT, LLC 02/14/2025 529,650 $43.36 M   14.16% 0.43%
FRED ALGER MANAGEMENT, LLC 02/14/2025 523,007 $42.81 M   -57.95% 0.42%
LAZARD ASSET MANAGEMENT LLC 02/14/2025 486,764 $39.85 M   100.00% 0.39%
UBS ASSET MANAGEMENT AMERICAS INC 02/14/2025 472,964 $38.72 M   15.84% 0.38%
CORMORANT ASSET MANAGEMENT, LP 02/14/2025 425,000 $34.79 M   -57.50% 0.34%
BANK OF NEW YORK MELLON CORP 02/04/2025 421,938 $34.54 M   2.40% 0.34%
TIMESSQUARE CAPITAL MANAGEMENT, LLC 02/03/2025 413,637 $33.86 M   53.70% 0.33%
AMUNDI 02/07/2025 406,928 $32.99 M   -6.41% 0.33%
HOOD RIVER CAPITAL MANAGEMENT LLC 02/14/2025 401,442 $32.86 M   100.00% 0.32%

Vaxcyte, Inc. institutional Ownership - FAQ's

During the previous two years, 386 institutional investors and hedge funds held shares of Vaxcyte, Inc.. The most heavily invested institutionals were:

FMR LLC: 13.09 M

VANGUARD GROUP INC: 11.96 M

BlackRock Funding, Inc. /DE: 11.11 M

JANUS HENDERSON GROUP PLC: 10.58 M

RA CAPITAL MANAGEMENT, L.P.: 8.69 M

Capital Research Global Investors: 6.21 M

113.83% of Vaxcyte, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 154.49 M shares in the last 24 months. This purchase volume represents approximately $13.28 B in transactions.